# Neuralink Raises $650M Series E at $9B Valuation to Scale BCI Implants

> financing · REPORTED · 2025-06-02

Neuralink closed a $650 million Series E round in June 2025, valuing the company at approximately $9 billion, with participation from ARK Invest, Sequoia Capital, and Founders Fund. The funding supports ongoing clinical trials, manufacturing scale-up, and plans for high-volume automated surgical procedures in 2026.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://sacra.com/c/neuralink/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.